| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
43 |
| issn |
1177-5475 |
| pageRange |
237-43 |
| publicationName |
Biologics : targets & therapy |
| startingPage |
237 |
| bibliographicCitation |
Flanigan J, Deshpande H, Gettinger S. Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer. Biologics. 2010 Sep 13;4():237–43. PMID: 20859451; PMCID: PMC2943196. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_268a0ade6e578b4d3c817700bf5be9c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d8294abffe6ca559393d74486984e7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c97f35cf3413f35039c6c192195117d |
| date |
2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/20859451
https://doi.org/10.2147/btt.s7223
https://pubmed.ncbi.nlm.nih.gov/PMC2943196 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36005
https://portal.issn.org/resource/ISSN/1177-5475 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 |